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ABSTRACT The mechanism of the all-or-none release of the contents of phospholipid vesicles induced by the antimicrobial
peptide cecropin A was investigated. A detailed experimental study of the kinetics of dye release showed that the rate of release
increases with the ratio of peptide bound per vesicle and, at constant concentration, with the fraction of the anionic lipid phos-
phatidylglycerol in neutral, phosphatidylcholinemembranes.Directmeasurement of the kineticsof peptide bindinganddissociation
from vesicles revealed that the on-rate is almost independent of vesicle composition, whereas the off-rate decreases by orders of
magnitude with increasing content of anionic lipid. A simple, exact model ﬁts all experimental kinetic data quantitatively. This is the
ﬁrst time that an exact kinetic model is implemented for a peptide with an all-or-none mechanism. In this model, cecropin A binds
reversibly to vesicles,whichat a certain point enteranunstable state. In this state, aporeprobablyopensandall vesicle contentsare
released, consistentwith the all-or-nonemechanism. This pore state is a state of thewhole vesicle, but doesnot necessarily involve
all peptides on that vesicle. No peptide oligomerization on the vesicle is involved; alternative models that assume oligomerization
are inconsistent with the experimental data. Thus, formation of well-deﬁned, peptide-lined pores is unlikely.
INTRODUCTION
Since their discovery over two decades ago (1), antimicrobial
peptides have received considerable attention (2–6) because
of their potential use in the development of alternatives to
traditional antibiotics. The amino-acid sequences of antimi-
crobial peptides from different organisms vary widely, but
many form an amphipathic a-helix upon binding to mem-
branes. No cell-surface receptors are involved in recognition
(7,8), indicating that target-cell specificity is determined by
the lipid bilayer itself. The antimicrobial peptides in this
class are cationic, which has led to the proposal that mem-
brane charge plays a crucial role in determining specificity of
eukaryotic peptides against bacterial cells (2), but this idea
has been challenged (9–11). Among the most studied pep-
tides are magainins, melittin, mastoparans, and cecropins,
which are all cationic. However, charge and amphipathicity
are the only similarities these peptides share, and the mech-
anism of specificity remains elusive.
Amphipathic a-helical peptides elicit the release of contents
from lipid vesicles and cells. Originally, they were thought to
form pores in membranes. According to the barrel-stave model
(12), a-helical bundles of six or more peptides would insert
into the membrane and form a water-filled pore, exposing the
hydrophilic face of the helices to water and the hydrophobic
face to the lipid bilayer interior. The model was believed to
apply to alamethicin, melittin, and d-lysin. However, it was
subsequently shown that it is unlikely for melittin (13) and
incorrect for d-lysin (14,15). It now appears that most peptides
follow other mechanisms (6,16), including the toroidal hole
model (17–19), the carpet model (3,16,20), the sinking raft
model (14,15), and other less structured types of pores (21).
The question of whether membrane disruption is the
function of these peptides is also still under debate (11,22). It
is possible that the real targets are intracellular components
and that membrane perturbation might be only a side effect.
Nevertheless, interaction with the bilayer is essential for the
function of these peptides.
Cecropin A is an amphipathic, antibacterial peptide syn-
thesized by Hyalophora cecropia, composed of 37 amino-
acid residues (1,24). Eight of these residues are basic (seven
Lys and one Arg) and two are acidic (Glu and Asp), which,
together with the N-terminus, produce a net 17 charge at
neutral pH. The C-terminus contributes no charge because
it is amidated. Cecropin A is monomeric (25) and unstruc-
tured in water (26), but in aqueous solution containing 15%
hexafluoroisopropanol it adopts a structure consisting of two
a-helical regions, one involving residues 5–21, and the other,
residues 24–37, separated by a Gly-Pro break (26,27). The
helical wheel projections of these two regions are shown in
Fig. 1, using the water/octanol transfer scale to assign hydro-
philic and hydrophobic residues (28). In its membrane-bound
form, cecropin A retains the helix-break-helix motif found
in solution, and both helices lie parallel to the membrane
surface (29,30).
Cecropin A kills Gram-negative bacteria, but mammalian
erythrocytes are resistant to it, probably because this poly-
cationic peptide does not bind well to zwitterionic, mam-
malian cell membranes (31). However, the importance of
anionic lipids in Gram-negative bacteria, such as Escherichia
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coli, for the activity of cecropin is still controversial (11).
The effects of cecropin A on membranes depend on con-
centration (25). At high concentrations, cecropin A releases
the contents from synthetic vesicles, but lower concentra-
tions are sufficient to dissipate electrochemical gradients.
Similarly, in E. coli, the peptide concentrations required to
dissipate membrane potential and kill the bacteria are lower
than those required to release cytoplasmic contents. This led
to the conclusion that its bactericidal activity stems from
dissipation of transmembrane electrochemical ion gradients
(25). On the other hand, more recent experiments in E. coli
revealed a similar concentration dependence for membrane
permeabilization, depolarization, and bactericidal activity
(32), suggesting that the antimicrobial effect is related to
membrane permeability changes induced by the peptide. In
any case, it is clear that the site of interaction of cecropin A
with membranes is the lipid bilayer, not a protein receptor,
since cecropin A composed of D-amino acids functions as
well as the natural, all-L form (7).
Computer modeling was used to propose that cecropin A
forms large ion channels in bilayers, consisting of 12 peptide
molecules each (33). More recent work also suggested ion
channel formation (25,32). On the other hand, cecropins
(34–36) and dermaseptins (20) were the peptides for which
the carpet model was originally proposed. Cecropin A, in
particular, was proposed to insert into the bilayer retaining
the parallel orientation to the membrane that it has on the
surface (29). This is consistent with the sinking raft model
(14,15) and conceptually similar to less structured types of
pores (21).
In the past few years, we have been examining the kinetics
of peptide-membrane interactions using a unified approach
that includes the quantitative analysis of experimental ki-
netics with rigorous models expressed as sets of (nonlinear)
differential equations, which are numerically solved and di-
rectly fit to the data. We have used this approach to study the
hemolytic peptide d-lysin from Staphylococcus aureus (14,15)
and, more recently, the cell-penetrating peptide transportan
10, tp10 (37). Both of these peptides are also amphipathic
and a-helical, but cause graded dye release from lipid ves-
icles. Here, we use the same methods to investigate the anti-
microbial peptide cecropin A, which behaves very differently
from d-lysin and tp10. On the basis of a rigorous analysis
of peptide binding and dye efflux kinetics, we propose a very
simple model that describes all our experimental data quan-
titatively. The model proposed is in agreement with the con-
cept that pore formation and dye release are a consequence of
a global, unstable state of the vesicle (38,39), which results
from its interaction with the peptides (19,40).
METHODS
Chemicals
Cecropin A (KWKLFKKIEKVGQNIRDGIIKAGPAVAVVGQATQIAK-
amide) was purchased from American Peptide (Sunnyvale, CA). A stock
solution was prepared by dissolving lyophilized cecropin A in deionized
water/ethyl alcohol 1:1 (v/v) (AAPER Alcohol and Chemical, Shelbyville,
KY). Stock peptide solutions were stored at –20C, and kept on ice during
experiments. 1-Palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC),
1-palmitoyl-2-oleoyl-sn-glycero-3-phosphatidylethanolamine (POPE), and
1-palmitoyl-2-oleoyl-sn-glycero-3-[phospho-rac-(1-glycerol)] (POPG), in
chloroform solution, were purchased from Avanti Polar Lipids (Alabaster,
AL). 7-Methoxycoumarin-3-carboxylic acid (7MC), 1-[[(6,8-difluoro-
7-hydroxy-4-methyl-2-oxo-2H-1-benzopyran-3-yl)acetyl]oxy] (Marina Blue
(trademark), MB) succinimidyl ester, 4-chloro-7-nitrobenz-2-oxa-1,3-diasole
(NBD) chloride, 8-aminonaphtalene-1,3,6-trisulfonic acid (ANTS) disodi-
um salt, and p-xylene-bis-pyridinium bromide (DPX) were purchased from
Molecular Probes/Invitrogen (Carlsbad, CA). Carboxyfluorescein (99% pure,
lot A015252901) was purchased from ACROS (Morris Plains, NJ).
Dimethylformamide was purchased from Mallinckrodt Baker (Paris, KY),
4-dimethylaminopyridine from Sigma-Aldrich (St. Louis, MO), and
n,n9-dicyclohexylcarbodiimide from ACROS. Organic solvents (high per-
formance liquid chromatography/American Chemical Society grade) were
purchased from Burdick & Jackson (Muskegon, MI). Lipids and fluorophores
were tested by thin-layer chromatography (TLC) and used without further
purification.
Synthesis of ﬂuorescent probes
The syntheses of NBD-POPE and MB-POPE were performed as described in
detail before in Frazier et al. (41), following the general method of Vaz and
Hallmann (42). 7MC-POPE (POPE labeled with 7MC, through an amide
bond to the amino group of the ethanolamine headgroup) was synthesized in a
FIGURE 1 Helical wheel projection of cecropin A. Residues 5–21 (A) and
24–37 (B). Solid symbols represent basic residues; dark shading, acidic
residues; light shading, hydrophobic residues; and open areas, hydrophilic
residues, according to the water/octanol transfer scale (28).
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similar way, with the following specific procedures. Organic solvents were
dried with molecular sieves (Sigma-Aldrich). POPE solutions in CHCl3 were
first dried in a rotary evaporator and the lipid film was dissolved in;0.5 mL of
dry CHCl3. Approximately 13 mg of 7MC dissolved in dry dimethylforma-
mide, 30 mL of 4 M 4-dimethylaminopyridine in dry CHCl3, and 25 mg
of n,n9-dicyclohexylcarbodiimide were sequentially added to a test tube
wrapped in aluminum foil, at room temperature. POPE (60mmol in;2 mL of
dry CHCl3) was then added to the reaction mixture, which was stirred in the
dark for ;16 h. The course of the reaction was monitored by TLC using
CH2Cl2/methanol (MeOH)/water 65:25:4 (v/v/v). The fluorescent probes
were identified with UV light and the phosphorus-containing lipids with
Zinzade’s reagent (43). Purification was performed on preparatory TLC, and
the product band was eluted from the silica with the same solvent system. An
approximate azeotrope (44) was then prepared by adding a volume of CHCl3
equal to 2.63 the volume of the probe solution, and the solvent was removed
by rotary evaporation at 60C. Finally, the product, 7MC-POPE, was dis-
solved in a minimal amount of dry CHCl3 and kept under nitrogen at 20C.
Absorbances were determined in MeOH (basic for MB) in a spectrophotom-
eter (Cary 1E UV-Vis; Varian, St. Helens, Australia) and lipid concentrations
were determined by the Bartlett phosphate assay (45). The absorption
maximum of 7MC-POPE occurs at 348 nm (e ¼ 2.9 3 104 M1 cm1 in
MeOH) and the emission maximum at 396 nm.
Preparation of large unilamellar vesicles
Large unilamellar vesicles (LUVs) were prepared by mixing the lipids in
chloroform in a round-bottom flask. For vesicles containing MB-POPE,
NBD-POPE, or 7MC-POPE, the probes were added in chloroform solutions
together with the lipids. The solvent was rapidly evaporated using a rotary
evaporator (model No. R-3000; Bu¨chi Labortechnik, Flawil, Switzerland) at
60–70C. The lipid film was then placed under vacuum for 4 h and hydrated
by the addition of buffer containing 20 mM MOPS, pH 7.5, 0.1 mM EGTA,
0.02% NaN3, and 100 mM KCl or appropriately modified as indicated be-
low. The suspension of multilamellar vesicles was subjected to five freeze-
thaw cycles to increase the degree of dye (carboxyfluorescein or ANTS/
DPX) encapsulation. The suspension was then extruded 103 through two
stacked polycarbonate filters of 0.1 mm pore size (Nucleopore; Whatman,
Florham, NJ), using a water-jacketed high pressure extruder (Lipex Bio-
membranes, Vancouver, Canada) at room temperature. Lipid concentrations
were assayed by the Bartlett phosphate method (45), modified as previously
described in Pokorny et al. (14).
Kinetics of cecropin A association with, and
dissociation from lipid vesicles
The kinetics of association of cecropin A with LUVs of POPC/POPG mix-
tures were recorded on a stopped-flow fluorimeter (model No. SX-18MV;
Applied Photophysics, Leatherhead, Surrey, UK). Fluorescence resonance
energy transfer (FRET) between the intrinsic Trp residue of cecropin A and
7MC-POPE incorporated in the lipid membrane were used to monitor pep-
tide binding and dissociation from LUVs. The Trp was excited at 280 nm
and transferred energy to 7MC-POPE, which absorbs maximally at 348 nm.
The emission of 7MC, with maximum at 396 nm, was measured using a
cutoff filter (model No. GG-385; Edmund Industrial Optics, Barrington, NJ).
After mixing, the concentration of peptide was 1 mM and the lipid varied
between 25 and 400 mM.
ANTS/DPX assay
Steady-state fluorescence measurements were performed in a spectrofluo-
rimeter (model No. 8100; SLM-Aminco, Urbana, IL) upgraded by software
(ISS, Champaign, IL). In the ANTS/DPX assay (46), which was performed
as described in detail by Ladokhin et al. (47,48), excitation was at 365 nm
(8 nm slit-width) and emission was at 515 nm (16 nm slit-width). The solu-
tion encapsulated in the LUVs contained 5 mM ANTS, 8 mM DPX, 20 mM
MOPS, pH 7.5, 0.1 mM EGTA, 0.02% NaN3, and 70 mM KCl. The titrating
solution contained 45 mM DPX, 20 mM MOPS, pH 7.5, 0.1 mM EGTA,
0.02% NaN3, and 30 mM KCl. After extrusion, the LUVs with encapsulated
ANTS and DPX were passed through a Sephadex-G25 column to separate
the dye in the external buffer from the vesicles. Typical concentrations were
of the order of 0.1–2 mM peptide and 500 mM lipid.
Carboxyﬂuorescein efﬂux experiments
Carboxyfluorescein (CF) efflux kinetics measurements were performed as
described before in the literature (15,37). Briefly, LUVs were prepared by
hydration of the lipid film in 20 mM MOPS buffer, pH 7.5, containing 0.1
mM EGTA, 0.02% NaN3, and 50 mM CF, to give a final lipid concentration
of 10 mM. After extrusion, CF-containing LUVs were passed through a
Sephadex-G25 column to separate the dye in the external buffer from the
vesicles. For fluorescence measurements, the suspension was diluted to the
desired lipid concentration in buffer containing 20 mM MOPS, pH 7.5, 100
mM KCl, 0.1 mM EGTA, and 0.02% NaN3, which has the same osmolarity
as the CF-containing buffer. The kinetics of CF efflux, measured by the
relief of self-quenching of CF fluorescence, were recorded in a spectroflu-
orimeter (model No. 8100; SLM-Aminco) upgraded by ISS (Champagne,
IL) with excitation at 470 nm and emission measured at 520 nm. The fastest
curves were recorded using a stopped-flow fluorimeter (model No. SX.18MV;
Applied Photophysics). The excitation was at 470 nm and the emission was
recorded through a long-pass filter (model No. OG 530; Edmund Industrial
Optics). The peptide concentration was 1 mM after mixing, in all experiments.
The fraction of CF released was determined by comparison of the fluorescence
with that obtained upon addition of Triton X-100, which dissolves the vesicles
and releases all the dye.
Analysis of binding kinetics
The reversible binding of peptides to lipid vesicles is described by Eq. 1. The
term Pw represents peptide in water, L represents lipid vesicles, and PL
represents peptide bound to the membrane; kon is the on-rate constant and
koff is the off-rate constant.
kon½L
Pw  PL
koff
: (1)
The corresponding differential equations,
dPw
dt
¼ kon Pw½L1 koff PL; (2)
dPL
dt
¼ kon Pw½L  koff PL; (3)
have the solution
PwðtÞ
Pwð0Þ ¼ Ce
kapp t1 ð1  CÞ; (4)
PLðtÞ
Pwð0Þ ¼ Cð1  e
kapp tÞ; (5)
where the apparent rate constant is
kapp ¼ kon½L1 koff ; (6)
and the constant C ¼ 1/(11 KD/[L]), where KD ¼ koff/kon is the equilibrium
dissociation constant. In these equations, [L] is the vesicle concentration,
which is expressed in terms of lipid concentration (1 LUV ’ 105 lipids).
Because the number of peptides bound per vesicle is always small, and
vesicles do not disappear when peptides bind, [L] is considered constant.
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The binding kinetics was analyzed using Eq. 5. The apparent rate constants,
obtained from single-exponential fits to the experimental binding kinetic
curves, were plotted against the lipid concentration, yielding a linear plot
whose slope is kon and y-intercept is koff (Eq. 6).
Analysis of dissociation kinetics
The dissociation kinetics experiment is represented by Eq. 7. Peptide (PL)
initially bound to donor vesicles (L) dissociates and irreversibly binds to
acceptor vesicles (L9). In the experiment, the donors are mixed vesicles of
POPC/POPG, whereas the acceptors are pure POPG. Irreversible peptide
binding to the acceptors is assumed because the affinity of cecropin A for
pure POPG is much greater than for POPC/POPG mixtures and the accep-
tors are in excess.
koff kon9 ½L9
PL  Pw / PL9
kon½L
: (7)
The solution of this equation is a decay function with a main apparent rate
constant that is a function of kon, koff, k9on; and the concentrations of vesicles,
kapp ¼ 1
2

ðkoff 1 kon½L1 k9on½L9Þ

ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
ðkoff 1 kon½L1 k9on½L9Þ2  4koff k9on½L9
q 
: (8)
If the concentration of donor vesicles is decreased while the concentra-
tion of acceptor vesicles remains the same, the likelihood of peptide re-
turning to the donor vesicles decreases. In the limit of zero donor vesicle
concentration, kapp becomes the real koff (Fig. 2). This limit is of course not
physically realizable, but if the dissociation experiment is performed as a
function of donor concentration and kapp is plotted against the donor lipid
concentration [L], the y-intercept provides a more accurate estimate of koff.
When cecropin A dissociates from the donor vesicles, energy transfer
from its Trp to 7MC-POPE on the membrane decreases, resulting in a decay
of the fluorescence emission of 7MC-POPE as a function of time, F(t). The
apparent rate constant (kapp) for this decay was obtained by fitting the
experimental kinetic dissociation curves with a single-exponential decay
function (Eq. 4). Given the magnitudes of the rate constants and the lipid
concentrations, this is the expected behavior from the simple description
provided by Eq. 7 and was found in most cases. (Strictly, a second apparent
rate exists, but its amplitude is negligible with the experimental parameters.)
Departures from this simple picture may lead to deviations from a single
exponential; indeed, in some cases this did not yield an acceptable fit, though
the approximate lifetime was still correct. Rather than using a more com-
plicated analysis in those cases, kapp was obtained from the apparent mean
lifetime (t) defined by (49,50):
t ¼
Z
dFðtÞ
dt
t dt
Z
dFðtÞ
dt
dt; (9)
kapp ¼ 1=t: (10)
In practice, this is equivalent to an amplitude-weighted average of the
time constants in a multiexponential decay. All curves could be reasonably
well fit with, at most, a double-exponential decay,
y ¼ aet=t1 1 ð1  aÞet=t2 (11)
yielding
t ¼ at11 ð1  aÞt2: (12)
Analysis of carboxyﬂuorescein efﬂux kinetics
The sets of differential equations describing the model used (Eqs. 13–17,
below) and many other (nonlinear) models tested were solved by numerical
integration with a fifth-order Runge-Kutta method with constant step size
(51). The numerical solution was fit directly to the experimental data with a
simplex algorithm (51) on a Linux workstation with in-house FORTRAN
code programs, using the f95 compiler (Numerical Algorithms Groups,
Oxford, UK).
In the analysis of carboxyfluorescein efflux, kon and koff were fixed at the
values obtained from the binding and dissociation kinetics. Therefore, only
three additional parameters are necessary: the rate constants for formation
and relaxation of the pore state, k1 and k2, and the efflux rate constant keflx,
which describes the rate at which dye escapes from the vesicle in the pore
state (see next section for definitions). Because keflx strongly correlates with
k2 it was fixed (at 100 M
1 s1) in the analysis. That correlation arises
because the shorter the lifetime of the pore state, the smaller the amount of
dye that can escape until the vesicle relaxes. Therefore, if both of these rate
constants are large enough, only the ratio keflx/k2 is significant. Furthermore,
we found that k1 can also be fixed because, over a broad range of values of
k1 and k2, the fits only depend on their ratio k1/k2, which we call b. Thus,
the model has only one truly free parameter, b. (In practice, k1 was fixed at
0.01 s1, and only k2 was allowed to vary.) The ratio b was adjusted by
requiring that one value globally fit the CF efflux kinetics for all lipid
concentrations pertaining to each lipid composition. Of course, b can be
different for different compositions of the vesicles; but within each com-
position, it is the same for all lipid concentrations. It is thus a very constrained
parameter. It turns out that b does not vary much with lipid composition of
the vesicles, either. Then, a slight variation of b within each lipid com-
position was allowed to better fit the curves for the different lipid con-
centrations individually, and to obtain an estimate of the error. The mean
values of those fits and their corresponding standard deviations are listed in
Table 1. In addition, an amplitude factor (0.80–1.15) was allowed for each
curve. This corrects for any experimental error in the determination of the
maximum dye release.
For the CF efflux reverse experiment, where donor (empty) vesicles were
preequilibrated with cecropin A, an additional block of two equations was
added, describing the time-dependence of the bound states initially present:
peptide associated with the vesicle surface and peptide in the pore state of the
vesicles. This block is similar to Eqs. 14–16, appropriately modified. The
initial conditions were calculated from the integrated equations in the for-
ward reaction, for a period equal to the preincubation time of cecropin with
empty vesicles, as before (15,37).
THE MODEL
The model depicted in Fig. 3 was used to analyze the CF
efflux kinetics. As shown experimentally below, cecropin A
FIGURE 2 Theoretical plot of kapp for dissociation of peptide from vesicles
as a function of the concentration of donor lipid (Eq. 8). The plot was gen-
erated with the experimental parameters for POPC/POPG 70:30 (Table 1).
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induces all-or-none dye release from vesicles, which means
that vesicles are either full of CF or empty, and the state from
which leakage occurs must be transient and not much pop-
ulated. The model has four peptide states: Pw, cecropin as an
unstructured monomer in water (Fig. 3 A); PfullL ; cecropin
bound, as an a-helix, to the membrane surface of full vesicles
(Fig. 3 B); P*, cecropin in the pore state of the vesicles (Fig.
3 C); and PemptyL ; cecropin bound to empty vesicles (Fig. 3 D).
The rate constants kon and koff describe binding to, and
dissociation from, vesicles (full or empty). Then, there is a
certain probability, proportional to a rate constant k1, that a
vesicle with surface-associated peptides will enter a pore
state. At this point, the membrane yields and all dye is re-
leased from that particular vesicle. The pore state is unstable
and relaxes to an empty vesicle state with a rate constant k2.
The peptide can dissociate from the membrane and bind to
another vesicle, with the same rate constants kon and koff,
continuing the cycle of vesicle permeabilization. Peptides
can, of course, also bind to empty vesicles, or dissociate
from full vesicles without having caused dye release. The
existence of empty vesicles is important for the kinetics
because they compete with the full vesicles for peptide
binding, therefore slowing down the observed rate of dye
release, especially at later times.
The efflux itself, which occurs from the pore state P*, is
described by another rate constant, keflx. The efflux rate
observed macroscopically, expressed as the increase in the
fraction of CF outside (Eq. 17), is the product of three
factors: keflx, the concentration of peptides in the pore state of
the vesicle per unit of lipid membrane P*/[L], and the
fraction of vesicles still full of CF, f full. Because dye release
induced by cecropin A follows an all-or-none mechanism,
the fraction of empty vesicles f empty is identical to the
fraction of CF released, CFout. Similarly, the fraction of
intact vesicles, f full, is identical to the fraction of CF still
inside the vesicles, (1 – CFout). Thus, the fractions f
full and
f empty are not additional variables, but are directly deter-
mined from the normalized, experimental CF release.
The kinetic mechanism that corresponds to this model
(Fig. 3) is expressed by the set of differential equations 13–17:
dPw
dt
¼ koffðPfullL 1PemptyL Þ  kon½LPw (13)
dP
full
L
dt
¼ kon f full½LPw  ðkoff 1 k1ÞPfullL (14)
dP

dt
¼ k1PfullL  k2P (15)
dP
empty
L
dt
¼ k2P1 kon f empty½LPw  koffP emptyL (16)
dCFout
dt
¼ keflxð1  CFoutÞP=ðvo½LÞ: (17)
In this scheme, the superscripts full or empty indicate
whether or not the vesicles contain CF. All concentrations of
peptide species, in water- or membrane-bound, are expressed
relative to the total aqueous solution volume. For example,
the concentration of bound peptide relative to the lipid is
pL ¼ PL/(vo[L]), PL being its concentration relative to water.
The factor vo ¼ 0.6/2 M1 is approximately one-half the
specific molar volume of the hydrophobic portion of a lipid
(;0.6 M1). Division by 2 corrects [L] for the two leaflets of
TABLE 1 Cecropin A on- and off-rate constants, equilibrium dissociation constants, and pore formation/relaxation ratio (b) for
POPC/POPG vesicles
Vesicle composition Binding kinetics Dissociation kinetics Dissociation constant* Pore state
POPC/POPG kon (M
1s1) koff (s
1) koff (s
1) Kd (mM) b ¼ k1/k2
50:50 (5.2 6 0.2) 3 105 7 6 2 0.125 6 0.002 0.24 (2.6 6 0.3) 3 103
70:30 (4.3 6 0.4) 3 105 46 6 4 24 6 1 56 (0.9 6 0.2) 3 103
80:20 (3.9 6 4.0) 3 105 170 6 40 105 6 6 270 (1.6 6 0.1) 3 103
90:10 NDy ND 160 6 15 — —
100:0z 2.8 3 105 300 300 1000 —
The rate constants were obtained from the fits of experimental kinetics to the model. The error is estimated from the fits using the linear regression (kon and
koff) or the variance in fitting the individual curves (b). The two other rate constants in model the were held fixed (keflx ¼ 100 M1 s1 and k1 ¼ 0.01 s1).
*Calculated using kon from binding and koff from dissociation kinetics.
yNot detectable; binding was too weak to produce a signal.
zEstimated by extrapolation (Fig. 8).
FIGURE 3 Model for the interaction between cecropin A and lipid
vesicles. (A) Cecropin in solution, (B) bound to the membrane surface of
dye-loaded vesicles, (C) associated with vesicles in the pore state, and (D)
bound to the surface of empty vesicles. Dye efflux occurs only from the pore
state.
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the lipid bilayer. (However, the only effect of vo is to change
slightly the numerical value of keflx.) The total concentration
of lipid vesicles is [L], the concentration of full vesicles is
f full[L], and the concentration of empty vesicles is fempty[L].
[L] is expressed in terms of lipid concentration and con-
sidered constant, because the vesicles do not disappear upon
interaction with the peptide. Thus, P* is the concentration
of peptide in the vesicle state that releases CF (Fig. 3 C),
expressed relative to the solution volume. However, it is the
concentration of P* per unit of membrane that is relevant for
dye efflux, because the larger the number of pores per unit of
membrane area, the faster the efflux. Therefore, in Eq. 17, P*
is divided by the lipid concentration, [L].
As an example of the behavior of the model, Fig. 4 shows
the fractions of the different states of the peptide as a
function of time, using the parameters determined from an
experiment where a 25 mM lipid sample of POPC/POPG
50:50 was mixed with 1 mM cecropin A at time zero. The
fraction of peptide in the pore state (right side y-axis) is
shown as the shaded curve, at a magnification of 1003. This
pore state peaks close to the beginning but is always a very
small fraction of the system. The other curves (left side y-axis)
represent peptide in aqueous solution (dotted line), peptide
bound to full vesicles (solid line), and peptide bound to empty
vesicles (dashed line).
RESULTS
Binding and dissociation kinetics
The kinetics of binding of cecropin A to lipid vesicles were
measured by stopped-flow fluorescence. Cecropin A con-
tains a Trp residue close to the N-terminus, which shifts its
emission maximum from 350 to 330 nm upon binding to the
membrane (Fig. 5 A), indicating that the N-terminus
becomes embedded in the acyl-chain region of the bilayer.
This change in emission could be used to monitor binding,
but the signal/noise ratio is not very large. Therefore, we used
instead the Fo¨rster resonance energy transfer (FRET) between
the Trp residue of cecropin A and a lipid fluorophore, 7MC-
POPE, incorporated in the bilayer. This probe, with an
absorption maximum at;350 nm and emission at;400 nm,
functions as an energy transfer acceptor for the Trp (Fig. 5
B). When the Trp is excited at 280 nm, the emission intensity
of 7MC-POPE increases upon cecropin A binding to the
membrane.
The increase in fluorescence emission intensity of 7MC-
POPE was monitored upon mixing of peptide with vesicles
(Fig. 6, left). The kinetic binding curves thus obtained were
fit with a single exponential function (Eq. 5) to obtain the
apparent rate constant (kapp). A plot of kapp against lipid
concentration yields a linear fit (Fig. 6, right) in which the
y-intercept is koff and the slope is kon (Eq. 6). The rate
constants for cecropin A binding and dissociation for
mixtures of POPC/POPG 50:50, 70:30, 80:20, and 90:10
were obtained from those fits and are listed in Table 1. The
values of kon are just below the diffusion limit, which is
;106 M1 s1, expressed in terms of lipid concentration,
and they increase weakly with the POPG content of the
vesicles, only doubling from the smallest (pure POPC) to the
largest kon (POPC/POPG 50:50).
The value of koff obtained from the binding kinetics can
have a considerable error, particularly if the y-intercept
occurs close to the origin. Therefore, to better determine koff,
a dissociation kinetics experiment was performed, using the
same energy transfer pair. Cecropin A was preincubated with
vesicles of POPC/POPG 50:50, 70:30, and 80:20 containing
1 mol % 7MC-POPE (donors), which were then mixed in the
stopped-flow system with pure POPG vesicles containing no
probe (acceptors). Because binding of cecropin A is much
stronger to pure POPG, once dissociation from the donors
occurs, the peptide is most likely to bind to the acceptors. To
reinforce the irreversibility of the process, the concentration
of acceptors was 500 mM, always larger than the donors
concentration, which varied from 50 to 300 mM. These
experiments were performed both with long and very short
incubation times with donors; the results were the same.
Representative kinetic curves for the various lipid compo-
sitions examined are shown in Fig. 7 (left). The plots of
the apparent off-rate constant against the concentration of
donor lipid are also shown in Fig. 7 (right). These plots are
expected to exhibit the lipid concentration dependence
shown in Fig. 2 (Eq. 8), and, by and large, they do. In the
limit of zero donor concentration, kapp becomes koff. The
values thus obtained are listed in Table 1. They are similar,
within experimental error, to those obtained from the binding
kinetics, but generally slightly smaller. We do not have a
good explanation for this slight discrepancy, but we believe
the values obtained from the dissociation experiment are
more reliable because they are more direct. Clearly, the off-
FIGURE 4 Fractions of the different states of the peptide as a function of
time calculated from the model. The shaded line (scale on the right side
y-axis) represents the fraction of peptide in the transient pore state, at a
magnification of 1003 compared to the other curves. The solid curves (scale
on the left side y-axis) represent the states of the peptide in aqueous solution
(dotted line), bound to full vesicles (solid line), and bound to empty vesicles
(dashed line). The parameters used correspond to mixing 25 mM POPC/
POPG 50:50 with 1 mM cecropin A.
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rate constants decrease sharply as the POPG content of the
vesicles increases, varying from ;300 s1 for pure POPC to
;0.1 s1 for POPC/POPG 50:50.
Binding of cecropin A to pure POPC is extremely weak,
consistent with a negligible efflux observed, and it was not
possible to determine kon and koff from binding kinetics.
However, it was possible to estimate those rate constants by
extrapolating to pure POPC the values of kon and koff
obtained for POPC/POPG mixtures as a function of POPC
content (Fig. 8). As the fraction of POPC in POPC/POPG
mixtures increases, kon decreases linearly (Fig. 8 A) and koff
increases exponentially (Fig. 8 B). Extrapolation of those
lines to 100% POPC yields estimates of kon and koff for pure
POPC, which are also listed in Table 1. The equilibrium
dissociation constant calculated from KD ¼ koff/kon is
;1 mM, confirming the very weak binding to pure POPC
vesicles.
Mechanism of dye release
The mechanism by which cecropin A causes dye to leak
from lipid vesicles was determined using the ANTS/DPX
assay (46–48). The dye release mechanism may be all-
or-none, in which some vesicles lose all of their contents
while others are not affected; or it may be graded, in which
all vesicles lose part of their contents. In this assay, a fluo-
rophore, ANTS, is encapsulated in the vesicles together with
a fluorescence quencher, DPX. The peptide induces release
FIGURE 5 (A) Emission shift of the Trp of cecropin A
upon binding to vesicles. The shaded line is 1 mM cecropin
A in solution and the solid line is 1 mM cecropin A in the
presence of 100 mM POPC/POPG 50:50 vesicles. (B)
Energy transfer from the Trp to 7MC-POPE in vesicles.
The dashed line is 1 mM cecropin A in solution; the solid
line is 1 mM cecropin A in the presence of 100 mM POPC/
POPG 50:50 vesicles containing 1 mol % 7MC-POPE; and
the shaded line is 100 mM POPC/POPG 50:50 vesicles
containing 1 mol % 7MC-POPE without cecropin A.
Excitation is always at 280 nm. The intensity change at 400
nm was used to monitor binding and dissociation.
FIGURE 6 Kinetics of cecropin A binding to vesicles of
POPC/POPG 50:50 (A and B), 70:30 (C and D), and 80:20
(E and F). On the left, the shaded curves are experimental
binding kinetics recorded with 25 mM lipid and 1 mM
cecropin A (;10 traces were averaged to improve the
signal/noise ratio); the solid line is a single-exponential fit
to the data (Eq. 5). On the right, the apparent rate constant
(kapp) is plotted against lipid concentrations to obtain kon
from the slope and koff from the y-intercept (Eq. 6).
Because cecropin binds weakly to POPC/POPG 80:20,
these data have considerably larger scatter.
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of both, and the fluorescence from ANTS that escapes to the
external solution is titrated by additional DPX. The observed
fluorescence is then only due to ANTS remaining inside the
vesicles. If the release is all-or-none, the degree of quenching
in the vesicles is independent of the amount of ANTS and
DPX released, because the vesicles are either intact or com-
pletely empty. Only the intact vesicles contribute to the
signal, and since the DPX concentration in the intact vesicles
does not change, neither does the degree of quenching. The
assay was performed for cecropin A with vesicles of POPC/
POPG 50:50 and 80:20. The experimental data clearly show
that cecropin A induces all-or-none release (Fig. 9). As the
fraction of fluorescence outside (fout) of the vesicles in-
creases, the fluorescence from within the vesicles remains
the same (Qin), resulting in a straight line with zero slope. If
the release were graded, only some of the fluorophore would
be released along with the quencher. The fluorescence of
ANTS remaining in the vesicles would increase because the
quencher concentration had also been lowered. The degree
of quenching would then become a function of the amount
of ANTS and DPX released. The dashed line in Fig. 9 rep-
resents qualitatively the type of function that would corre-
spond to graded release.
To ensure that the all-or-none dye release observed was
not an artifact caused by vesicle fusion, the ANTS/DPX as-
say was repeated with tenfold lower concentrations of both
lipid and peptide. The rationale is that fusion is less likely at
lower lipid concentrations and, if the real outcome were
graded release, it would be apparent under those conditions.
Although the data had more scatter because of the small
concentrations, the plot still indicated an all-or-none release
(not shown).
However, because of the noisier data, we directly tested for
peptide-induced vesicle fusion. Two populations of vesicles
were labeled with either a lipid FRET donor, MB-POPE, or
an acceptor, NBD-POPE (41), and equal amounts of those
suspensions were mixed. If fusion occurred upon addition of
cecropin A to this suspension, energy transfer would be
FIGURE 7 Kinetics of cecropin A dissociation from
vesicles of POPC/POPG 50:50 (A and B), 70:30 (C and D),
80:20 (E and F), and 90:10 (G and H). Peptide, at a
concentration of 2 mM, was incubated with 100–600 mM
of POPC/POPG 50:50, 70:30, and 80:20, for 30, 40, and
60 min, respectively, and then mixed in the stopped flow
with 1 mM POPG LUVs. The concentrations after mixing
are half of those values. On the left, the shaded curves
represent dissociation kinetics recorded with 50 mM lipid
and 1 mM cecropin A (;10 traces were averaged to
improve the signal/noise ratio); the solid line is a one- or
two-exponential fit to the data. On the right, the kapp
obtained from those fits is plotted against the concentration
of donor lipid to obtain koff from the y-intercept (compare
with theoretical plot in Fig. 2).
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expected, but none was observed (Fig. 10 A). As a control,
peptide was added to vesicles labeled with both donor and
acceptor probes at half the concentration, to determine the
maximum possible amount of energy transfer between MB-
POPE and NBD-POPE. Energy transfer is observed in this
case (Fig. 10 B), and appears to decrease with addition of
cecropin A. On closer examination, we found that what
appears to be a change in energy transfer is in fact the result
of a direct effect of cecropin A on the fluorescence of each
lipid probe. In an additional control (not shown), peptide was
added to vesicles containing either MB-POPE or NBD-
POPE. These results showed that cecropin A directly in-
creases the emission intensity of MB-POPE by ;25% and
decreases the intensity of NBD-POPE by;15%, with hardly
any effect on energy transfer between them. In conclusion,
cecropin A does not cause vesicle fusion under the con-
ditions of the ANTS/DPX assay and induces all-or-none
release from POPC/POPG vesicles.
Carboxyﬂuorescein efﬂux kinetics
Addition of cecropin A to phospholipid vesicles containing
CF encapsulated at high, self-quenching concentration causes
efflux and consequent increase in fluorescence of CF that
FIGURE 8 Cecropin A on- and off-rate constants as a function of the
POPC content in POPC/POPG mixed vesicles. (A) kon and the extrapolation
to 100% POPC. (B) koff and the extrapolation to 100% POPC. The circles are
from binding kinetics (Fig. 6) and the squares are from dissociation kinetics
experiments (Fig. 7).
FIGURE 9 ANTS/DPX assay to determine the mechanism of release by
cecropin A. The quenching function inside, Qin ¼ Fi/Fimax, which is the ratio
of ANTS fluorescence inside the vesicle in the presence (Fi) and absence
(Fi
max) of quencher (DPX), is plotted against the ANTS fraction outside the
vesicles, fout, corrected for incomplete entrapment as described by Ladokhin
et al. (48). The horizontal solid line is the result expected for all-or-none
release and the dashed line for graded release. The concentrations encap-
sulated were 5 mM ANTS and 8 mM DPX. The data points correspond to
experiments on 12 independent vesicle preparations. Because there are slight
variations in the degree of encapsulation in different preparations, the Qin
data were first normalized to the average initial fluorescence (in the absence
of peptide), to bring all data sets to a common origin. The standard
deviations for Qin and fout were calculated for each group of data points and
are shown as error bars.
FIGURE 10 Test for possible vesicle fusion induced by cecropin A. (A)
Cecropin A does not cause energy transfer when MB-POPE and NBD-
POPE are located on separate vesicles. Identical volumes of vesicle
suspensions of POPC/POPG 50:50 containing either 1 mol % MB-POPE or
1.5 mol % NBD-POPE were mixed and fluorescence emission spectra were
collected before and after addition of cecropin A, exciting the MB at 367 nm.
The solid line is the spectrum of vesicles without peptide (identical for all
lipid concentrations after normalization by the MB peak at 463 nm). The
shaded lines are spectra of vesicles for lipid concentrations of 25, 50, 100,
200, and 500 mM upon addition of 1 mM cecropin A. (B) Energy transfer
between MB-POPE (0.5 mol %) and NBD-POPE (0.75 mol %) incorporated
in the same vesicles (POPC/POPG 50:50) before and after addition of 1 mM
cecropin A. The solid line is the spectrum of vesicles without peptide
(identical for all lipid concentrations after normalization by the NBD peak at
530 nm). The shaded lines are normalized spectra of vesicles, upon addition
of 1 mM cecropin A, for lipid concentrations of 25 (highest peak at 463 nm),
50, 100, 200, and 500 mM (closest to the solid line).
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escapes from the vesicle lumen. The rate of CF fluorescence
increase was used to follow the efflux kinetics. Cecropin A
(1 mM) was mixed with LUVs, varying the lipid concentra-
tion from 25–400 mM, and the kinetics of dye efflux were
monitored. This experiment was performed for pure POPC
and POPG (Fig. 11), and for mixtures of POPC/POPG 50:50,
70:30, and 80:20 (Fig. 12, top panels). Efflux from pure
POPC is almost zero (Fig. 11 A), while efflux from POPG is
fast (Fig. 11 B). This was expected because POPC is
zwitterionic and cecropin A requires anionic membranes to
bind. As shown in Fig. 12 (top, shaded curves), increasing
the content of anionic lipid (POPG) increases the efflux rate.
It is also apparent that as the lipid concentration increases,
the rate of efflux decreases, because the number of peptides
bound per vesicle decreases.
To further constrain the analysis of the CF efflux data, a
reverse experiment was carried out: the efflux kinetics was
measured after cecropin A was preincubated for ;1 h with
empty vesicles (donors), which were then mixed with vesi-
cles containing CF (acceptors). Now, cecropin must disso-
ciate from the donor vesicles, back into solution, before it
can bind to acceptor vesicles and induce CF release. This
experiment was performed for POPC/POPG 50:50, 70:30,
and 80:20, the lipid composition of both types of donor and
acceptor vesicles being identical in each case (Fig. 12, bottom
panels, shaded curves). The CF efflux kinetics in the reverse
experiments are very similar to those in the direct addition
experiments performed with the same lipid and peptide final
concentrations (Fig. 12, top panels, 50 mM lipid curves).
Thus, after incubation with empty vesicles, cecropin A is able
to release CF with almost identical kinetics as if it were added
directly to the full vesicles. This indicates that the peptides
can readily desorb from the donors and are then free to act on
the newly added acceptor vesicles. In Fig. 12, the thin solid
lines are the fits to the CF efflux experiments, with the model
represented in Fig. 3, as described in the next section.
Analysis of CF efﬂux kinetics
Many different models to explain the mechanism of cecropin
A were conceived and quantitatively tested against the ex-
perimental CF efflux kinetics (Fig. 12, shaded curves).
Among the model variations tested were several versions that
included oligomerization of cecropin A in the membrane.
None of those models could fit the data. Of all models, only
the one depicted in Fig. 3 was able to fit all the data in a global
manner. In this model, cecropin A, which is monomeric in
aqueous solution (25), binds reversibly to lipid vesicles. At
some point, the vesicle yields and releases all its contents, in
agreement with the all-or-none mechanism. The peptide can
still bind to, and dissociate from empty vesicles, with the same
kon and koff that apply to full vesicles. The kinetic mechanism
corresponding to this model is represented by Eqs. 13–17.
These equations were numerically integrated and directly fit
to the experimental CF efflux data. In those fits, the values of
kon and koff obtained from the binding and dissociation
kinetics, as well as keflx and k1, were used as fixed parameters.
The model has only one truly variable parameter, b ¼ k1/k2,
which was adjusted by a global fit to the CF efflux kinetics for
all lipid concentrations pertaining to each lipid composition.
The solid lines in the top panels of Fig. 12 are the best fits to the
data. The corresponding values for the complete set of param-
eters of the model and their standard deviations are indicated
in Table 1. We find that b does not vary much with lipid
composition, but is a minimum at POPC/POPG 70:30. The
dashed lines in the bottom panels of Fig. 12 are not fits, but are
the curves calculated for the reverse experiment using the
exact average values of the parameters obtained in the direct
addition experiment (Fig. 12, top panels). The agreement with
the data is already very good, and only a small adjustment of
b is necessary to produce the fits shown by the solid lines in
the three bottom panels.
DISCUSSION
Cecropin A binding to membranes
Binding of cecropin A to LUVs of pure POPC and POPC/
POPG mixtures is entirely reversible, which argues against
the peptide forming a stable pore. The on-rate constants for
the POPC/POPG mixtures and for pure POPC are similar to
each other and close to the diffusion limit. A slight trend for
larger kon with increasing anionic lipid content of the vesicles
FIGURE 11 Carboxyfluorescein efflux induced by cecropin A (1 mM)
from vesicles of (A) pure POPC (25 mM) and (B) pure POPG, for lipid
concentrations of 25 mM (fastest), 50, 100, and 200 mM (slowest). The
maximum possible fluorescence levels were determined by adding the
detergent Triton X-100 to the vesicle suspension at a concentration of 1%,
which dissolves the vesicles.
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is apparent, but kon only doubles from pure POPC to POPC/
POPG 50:50. On the other hand, koff is very sensitive to the
POPG content and decreases by three orders of magnitude
from POPC to POPC/POPG 50:50. The dependence of the
equilibrium dissociation constant, KD ¼ koff/kon, on anionic
lipid content is therefore determined by koff. Clearly, lipid
charge plays a major role in binding, as already noticed by
Silvestro et al. (25), who compared binding to pure POPC
with binding to vesicles containing 20 mol % anionic lipid
(1-palmitoyl-2-oleoyl-phosphatidic acid, POPA). The appar-
ent KD from their data for POPC/POPA 80:20 vesicles is
;300 mM, in good agreement with the value of KD ¼ 270
mM determined here. The values of KD tabulated by
Silvestro et al. (25) are much smaller, but that is because
the model used to analyze their data defines discrete binding
sites on the membrane. Our KD is conceptually equivalent to
a partition coefficient (28), and does not involve defined
binding sites; therefore, it should be compared directly with
their apparent KD. For pure POPC, both studies estimate KD
of ;1 mM.
Thus, the negative charge on the lipid vesicles, imparted
by the anionic lipid component (POPG), is important mainly
for cecropin A binding, which is the single most important
factor that determines the rate of CF release induced by
cecropin A. In fact, it is koff that determines the differences
between efflux from POPC/POPG 50:50, 70:30, and 80:20
vesicles. Vesicle charge, however, has a minimal effect on
the other rate constants: keflx and k1 were kept fixed, and b ¼
k1/k2 varies only weakly, and not monotonically, with POPG
content (Table 1). Thus, charge does not seem to be
important for the step that actually corresponds to pore
formation and bilayer permeabilization in the pore state. This
is in agreement with the observation that the permeabiliza-
tion step for POPC membranes is not any slower than for
anionic membranes (25). Suggestions have been made that a
complex can form between an anionic amphiphile, such as
POPG, and a cationic peptide, which could help translocate
the peptide across the membrane (52). This possible mech-
anism does not seem to operate in the case of cecropin A.
Thus, the electrostatic interaction between cecropin A and
the lipid is essential for good binding but not for disruption
of the bilayer. Cecropins should therefore act as broad-
spectrum antimicrobials against organisms with anionic
membranes. Consistent with this idea is the observation that
their genes are not subject to high mutation rates, unlike
other antimicrobial peptides (53).
Kinetics and mechanism of dye release
The rate of CF efflux increases with the P/L ratio, as is well
known (25). The significant new finding is that the same
model quantitatively describes the kinetics over a broad
range of P/L for three different vesicle compositions (Fig.
12). This strongly suggests that the same mechanism
FIGURE 12 Carboxyfluorescein ef-
flux from POPC/POPG mixtures in-
duced by direct addition of cecropin A
(top panels) to POPC/POPG (A) 50:50,
(C) 70:30, and (E) 80:20. In each top
panel, the shaded curves correspond to
lipid concentrations of 25, 50, 100, and
200 mM lipid (plus 400 mM in E). The
fastest curve is always that for 25 mM
lipid and the slowest is that for 200 mM
lipid (400 mM in E). The peptide
concentration is always 1 mM. The
bottom panels show the CF efflux
reverse experiments for the same ves-
icle compositions (shaded curves):
POPC/POPG (B) 50:50, (D) 70:30,
and (F) 80:20. Here, 60 mM donor
vesicles containing no CF were incu-
bated with 2 mM peptide for the amount
of time required to reach a plateau in the
fraction of dye released in the regular
CF efflux experiments (top). This
corresponded to incubation times of 30, 40, and 60 min for POPC/POPG 50:50, 70:30, and 80:20, respectively. After incubation with peptide, the empty
donor vesicles were mixed with an equal volume of 40 mM, CF-containing acceptor vesicles, resulting in a final 50 mM total lipid and 1 mM peptide
concentration. The maximum possible fluorescence levels were determined by adding the detergent Triton X-100 to the vesicle suspension at a concentration of
1%, which dissolves the vesicles. In all panels, the curves shown are averages of approximately four independent traces recorded on the same vesicle
preparation. In addition, the data was reproduced at least twice in independent vesicle preparations. In the top three panels, the thin solid lines are the fits of the
model of Fig. 3, and correspond to the integrated differential Eqs. 13–17. The values obtained for the only variable parameter in these fits, b ¼ k1/k2, are listed
in Table 1. The fits also used the values of kon and koff independently obtained from the binding and dissociation kinetics, and the fixed parameters keflx ¼ 100
M1 s1 and k1 ¼ 0.01 s1. In the bottom three panels, the dashed line is calculated using the exact values obtained from the corresponding fits in the top panels
(Table 1). Allowing for a slight adjustment of b to fit the reverse experiment curves, the solid line is obtained, which corresponds to the values b¼ 1.43 103
for (B) 50:50, (D) 1.0 3 103 for 70:30, and (F) 0.73 3 103 for 80:20.
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operates over that entire concentration range. Experiments
where cecropin was prebound to empty vesicles and then
mixed with CF-loaded vesicles (reverse experiment) yielded
CF efflux rates almost identical to those obtained by direct
mixing with the loaded vesicles, indicating that desorption
occurs rapidly and the peptide does not, in the main, occur in
the form of stable pores.
Cecropin A causes all-or-none release of the contents of
phospholipid vesicles (Fig. 9) and this is not an artifact due to
vesicle fusion. Evidence for the all-or-none dye release had
been presented before (25), but the range of induced release
had only been examined up to a fraction of 0.27, which could
be misleading. (Based on similarly limited data, the release
mechanism of melittin was believed to be all-or-none (25),
but subsequent data seems to indicate it is graded (54).) Now,
examination of the full range of release definitely establishes
the all-or-none mechanism for cecropin A. Knowing the re-
lease mechanism is essential to write a correct kinetic model
for efflux because this information is explicitly used in the
formulation of the differential equations (Eqs. 13–17).
The mechanism of the all-or-none release has been
explained for situations where the average number of pep-
tides bound per vesicle is very small, of the order of the
number of peptides necessary to form a pore (55). Some of
those vesicles have less than the average and retain their
contents, while others have more and release all contents.
This explanation, however, is not valid if the number of
peptides bound per vesicle is very large, of order 100, which
is the case for cecropin A in these experiments. A different
molecular mechanism must therefore operate here. What we
believe is happening is the following.
Mechanism of cecropin A
At low peptide concentration on the membrane the vesicles
remain tight to leakage (Fig. 3 B). As more peptide is bound,
the membrane accommodates it, oriented parallel to the
surface (29,30). The bound peptides probably cause bilayer
thinning (19,40,56) and positive curvature strain because of
the excess mass on the outer monolayer of the membrane
(15). A point of rupture is eventually reached where the
bilayer yields, allowing the contents to leak out all at once
(Fig. 3 C). The molecular conformation of the membrane in
this pore state may very well be that of a bilayer with one or
more toroidal pores (38–40,56,57). The usual concept is that
the toroidal pore is lined by the peptides, oriented perpen-
dicular to the membrane, and by the lipid headgroups (19).
We posit, in contrary, that the pores are not neatly lined by
the peptides, though a fraction of them also occurs in the
pores. Rather, the arrangement of peptides in the pores is
probably much more disorganized, and they occur also on
the membrane surface even in the pore state of the vesicles.
This is apparent in recent molecular dynamics (MD) sim-
ulations of a magainin analog (58). Experimentally, in most
lipids, the estimated fraction of the peptide melittin in the
pores is well below 1/2 for P/L # 1:25 (56), which is the
concentration range used here. The same is true for magainin
in POPC even at P/L 1:20 (18). It should be pointed out,
however, that the molecular arrangement of the peptides and
lipids in the toroidal pore model is still entirely conjectural.
The structure of these pores has never been determined.
The reason we believe the fraction of peptides in the pores
is small is that they desorb very readily from the vesicles, as
shown by the dissociation kinetics (Fig. 7) and the reverse
CF efflux kinetics experiments (Fig. 12). If the peptides were
mainly concentrated in the pore regions, they should be able
to translocate to the inner monolayer with the same like-
lihood as returning to the top monolayer, as soon as the tran-
sient pore state of the vesicle relaxes. If this were to happen,
the amount of peptide dissociation after preincubation with
donor vesicles, as well as its rate, would significantly de-
crease, which is inconsistent with those two experiments. Fur-
thermore, a concerted transition from a surface-associated to
an inserted state would exhibit a cooperativity that is com-
pletely absent from the dye release kinetics. On the contrary,
participation of some cecropin A molecules in a peptide/lipid
toroidal pore that is mainly unstructured is consistent with
the observation that cecropin A is always oriented parallel to
the membrane surface (29).
Peptide binding parallel to the membrane is postulated by
the carpet model (3,16,20); our results agree with this feature.
However, no extensive coverage of the membrane surface by
peptide occurs, nor is it required for function. Also, the vesi-
cles do not disintegrate or micellize, at least at the P/L ratios
used here. This is evident because the on- and off-rate con-
stants are exactly the same for intact and empty vesicles, and
for vesicles incubated with the peptides for as short a time as
possible and for very long times. One set of values of kon and
koff is sufficient to quantitatively describe all the data for
binding, dissociation, and CF efflux kinetics. That neither ex-
tensive coverage nor membrane micellization occur is in dis-
agreement with the most common picture of the carpet model.
It thus appears that the effect of cecropin A is the generation
of strain on the membrane, which is relieved by formation of
pores. Formation of toroidal pores in a bilayer under me-
chanical stress has been observed in MD simulations (59). We
believe this pore state to be a transient state of the whole
vesicle—hence the all-or-none mechanism of dye release.
This is consistent with the ideas of Brochard-Wyart et al. (38),
Karatekin et al. (39), and Huang (40). In this view, cecropin A
may cause membrane thinning and positive curvature strain,
which is relieved when the whole vesicle yields, opening up
pores that allow complete release of contents. The unstable
pore state of the vesicles relaxes when the mass imbalance
across the bilayer is dissipated, mainly through lipid transport
mediated by the pores, as also observed in MD simulations
(60), although some peptide translocation probably occurs as
well. If, for other peptides, dissipation of the imbalance occurs
faster than the complete leakage, the model may also account
for incomplete but all-or-none dye release.
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Minimal sequence requirements may be sufficient for
peptides to bind to, and permeabilize membranes by this
mechanism. It is clear that interaction with bacterial mem-
branes is necessary for function, and that it occurs at the level
of the lipid bilayer. Our model provides a good description of
this process. However, the question remains whether the
negative charge on the membrane is sufficient, or interaction
with intracellular targets is responsible for specificity (11).
CONCLUSION
The model developed for the interaction of cecropin A with
membranes is extremely simple (Fig. 3). It involves only
peptide monomers that bind reversibly and a pore state of the
vesicle. Yet, this model can quantitatively account for the
efflux kinetics as a function of lipid concentration and vesicle
composition with only one variable fit parameter, the ratio
between the rate of formation and relaxation of the pore state.
Its value is b ;103 for all vesicle compositions. In this in-
frequent state, the vesicles release essentially all their con-
tents, as required by the all-or-none release mechanism. Large
pores probably exist at this point, which eventually reseal. The
molecular structure of the pore state still needs to be deter-
mined, but does not seem to involve any specific peptide
arrangement. In this sense, we could call this a nonstoichio-
metric pore model.
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